DR AGARWAL'S EYE HOSP L Latest Share Price (DRAGARWQ)
TODAY IN ONE LINE
DRAGARWQ is little changed at ₹5077.50 — a quiet consolidation day, supported by recent strong earnings.
With a market cap of ₹2,454.59 Cr., it trades at a P/E of 32.20. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
DR AGARWAL'S EYE HOSP L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 19.1% and Profit up 44.0%
- ●High Capital EfficiencyROCE of 18.7% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 20.2%
- ●Healthy Operating MarginsOPM is structurally strong at 22.4%
- ●High Promoter HoldingPromoters hold 72.7% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.24x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest DR AGARWAL'S EYE HOSP L News
What changed recently?
Recent events, corporate actions, and announcements.
DR. AGARWAL'S EYE HOSP L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for DR. AGARWAL'S EYE HOSP L, framed against the sector median so the premium or discount is obvious at a glance.
DR. AGARWAL'S EYE HOSP L trades at a P/E of 32.20× and P/B of 7.09×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
DR. AGARWAL'S EYE HOSP L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for DR. AGARWAL'S EYE HOSP L — derived from the latest tape, not yesterday's close.
DR. AGARWAL'S EYE HOSP L last traded at ₹5,077.5 with an intraday range of ₹5,035–₹5,135 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹5077.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 5330.00 | +252.50 | +4.97% |
| R3 | 5230.00 | +152.50 | +3.00% |
| R2 | 5182.50 | +105.00 | +2.07% |
| R1 | 5130.00 | +52.50 | +1.03% |
| PIVOT | 5082.50 | 5.00 | 0.10% |
| CURRENT | 5077.50 | — | — |
| S1 | 5030.00 | -47.50 | -0.94% |
| S2 | 4982.50 | -95.00 | -1.87% |
| S3 | 4930.00 | -147.50 | -2.90% |
| S4 | 4830.00 | -247.50 | -4.87% |
DRAGARWQ is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹5110.5–₹5129
Trading Inside opening range
DR. AGARWAL'S EYE HOSP L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for DR. AGARWAL'S EYE HOSP L — consolidated or standalone — with margins, YoY growth and key ratios inline.
DR. AGARWAL'S EYE HOSP L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,454.59 Cr. and reported EPS of ₹48.38.
DR AGARWAL'S EYE HOSP L segment analysis : revenue and profit mix.
Disclosed business segments at DR AGARWAL'S EYE HOSP L with their share of revenue and profit, switchable between consolidated and standalone reporting.
DR AGARWAL'S EYE HOSP L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for DR. AGARWAL'S EYE HOSP L.
Our AI distills the core fundamental drivers supporting DR. AGARWAL'S EYE HOSP L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 42 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 15% would indicate weaker capital compounding.
DR. AGARWAL'S EYE HOSP L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — DR. AGARWAL'S EYE HOSP L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
DR. AGARWAL'S EYE HOSP L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for DR. AGARWAL'S EYE HOSP L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
DR. AGARWAL'S EYE HOSP L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for DR. AGARWAL'S EYE HOSP L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in DR. AGARWAL'S EYE HOSP L stood at 82.5% of traded volume, against a 20-day average of 71.1%.
DR AGARWAL'S EYE HOSP L announcements: results, concalls, ratings, M&A.
Filings DR AGARWAL'S EYE HOSP L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
DR AGARWAL'S EYE HOSP L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 44 documents below.
Insider Trading / SAST
The disclosure on closure of trading window is submitted.
AGM/EGM
32nd Annual General Meeting (AGM)- Results of the remote e-voting and e-voting during the AGM along with the Scrutinizer report, is submitted.
AGM/EGM
Summary of proceedings of the 32nd Annual General Meeting of the Company held on September 09, 2026, is submitted.
Company Update
Media Release - Launch of World''s first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.
Company Update
Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted
Investor decks & rating reports.
DR AGARWAL'S EYE HOSP L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue DR AGARWAL'S EYE HOSP L has declared, sequenced by announce and record date.
DR AGARWAL'S EYE HOSP L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About DR. AGARWAL'S EYE HOSP L: business, sector, key facts.
What DR. AGARWAL'S EYE HOSP L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
DR. AGARWAL'S EYE HOSP L is a listed Indian equity, listed as NSE: DRAGARWQ, BSE: 526783.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about DR. AGARWAL'S EYE HOSP L (DRAGARWQ).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of DR. AGARWAL'S EYE HOSP L (DRAGARWQ)?
The current share price of DR. AGARWAL'S EYE HOSP L (DRAGARWQ) is ₹5,077.50. Today, the stock has gained by ₹0.50 (0.01%), trading in a range of ₹5,035.00 to ₹5,135.00. The stock opened at ₹5,114.00 with a trading volume of 1,328 shares.
02Is DR. AGARWAL'S EYE HOSP L stock a good investment for long-term?
DR. AGARWAL'S EYE HOSP L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,454.59 Cr., P/E ratio of 32.2, ROE of 20.24%, and ROCE of 18.74%. The dividend yield stands at 0.14%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of DR. AGARWAL'S EYE HOSP L stock?
The 52-week high price of DR. AGARWAL'S EYE HOSP L (DRAGARWQ) is ₹6,059.70, while the 52-week low is ₹4,600.00. Currently trading at ₹5,077.50, the stock is 10.38% above its 52-week low and 16.21% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy DR. AGARWAL'S EYE HOSP L stock at the current price?
Whether to buy DR. AGARWAL'S EYE HOSP L stock at ₹5,077.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 32.2 and P/B ratio of 7.09. Today's performance shows a gain of 0.01%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of DR. AGARWAL'S EYE HOSP L and when is the next dividend?
DR. AGARWAL'S EYE HOSP L offers a dividend yield of 0.14%, which means for every ₹100 invested at the current price of ₹5,077.50, you can expect to receive approximately ₹0.14 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of DR. AGARWAL'S EYE HOSP L?
DR. AGARWAL'S EYE HOSP L's key financial metrics include: P/E Ratio: 32.2, P/B Ratio: 7.09, ROE: 20.24%, ROCE: 18.74%, Dividend Yield: 0.14%, EPS: ₹48.38, Book Value: ₹716.56, and Debt-to-Equity: 0.24. The company's market cap stands at ₹2,454.59 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is DR. AGARWAL'S EYE HOSP L stock performing today in the market?
DR. AGARWAL'S EYE HOSP L stock opened at ₹5,114.00 and is currently trading at ₹5,077.50, showing a gain of ₹0.50 (0.01%). The intraday high is ₹5,135.00 and low is ₹5,035.00. The trading volume stands at 1,328 shares, indicating moderate market participation today.
08What is the P/E ratio of DR. AGARWAL'S EYE HOSP L and what does it indicate?
DR. AGARWAL'S EYE HOSP L has a Price-to-Earnings (P/E) ratio of 32.2, which means investors are willing to pay 32.20 for every ₹1 of earnings. With an EPS of ₹48.38, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about DR. AGARWAL'S EYE HOSP L (DRAGARWQ) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.